Shasun Pharmaceuticals gains on reporting stellar Q1 numbers

03 Aug 2012 Evaluate

Shasun Pharmaceuticals is currently trading at Rs. 125.50, up by 0.70 points or 0.56% from its previous closing of Rs. 124.80 on the BSE.

The scrip opened at Rs. 126.00 and has touched a high and low of Rs. 128.00 and Rs. 123.00 respectively. So far 145960 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 141.30 on 19-Jul-2012 and a 52 week low of Rs. 38.10 on 16-Dec-2011.

Last one week high and low of the scrip stood at Rs. 132.80 and Rs. 119.00 respectively. The current market cap of the company is Rs. 686.02 crore.

The promoters holding in the company stood at 40.96% while Institutions and Non-Institutions held 24.12% and 34.93% respectively.  

Shasun Pharmaceuticals has reported results for first quarter ended June 30, 2012.

The company has reported a surge of 102.34% in its net profit at Rs 13.82 crore for the quarter under review as compared to Rs 6.83 crore for the same quarter in the previous year. The total income from operation of the company has increased by 32.26% at Rs 265.60 crore for Q1FY13 as compared Rs 200.82 crore for the corresponding quarter previous year.

Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R&D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.

Peers
Company Name CMP
Sun Pharma Inds. 1672.95
Dr. Reddys Lab 1166.45
Cipla 1386.00
Zydus Lifesciences 879.00
Lupin 2178.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×